scholarly article | Q13442814 |
P2093 | author name string | Andrew J Wilson | |
Dineo Khabele | |||
Deok-Soo Son | |||
Angelika K Parl | |||
P2860 | cites work | Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase | Q24563699 |
The many roles of histone deacetylases in development and physiology: implications for disease and therapy | Q24628821 | ||
Aspirin induces apoptosis through the inhibition of proteasome function | Q28199915 | ||
Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancer | Q28212231 | ||
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors | Q29547463 | ||
Cancer statistics, 2009 | Q29547625 | ||
Anticancer activities of histone deacetylase inhibitors | Q29616624 | ||
Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death | Q30434141 | ||
A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study | Q30445663 | ||
Nonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health Study | Q33645700 | ||
Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. | Q34268195 | ||
Cancer of the ovary | Q34375262 | ||
Histone deacetylase inhibitors: signalling towards p21cip1/waf1. | Q36782509 | ||
Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas | Q36840303 | ||
Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer | Q36975194 | ||
Depsipeptide (FK228) as a novel histone deacetylase inhibitor: mechanism of action and anticancer activity | Q36990556 | ||
Early events in the pathogenesis of epithelial ovarian cancer | Q37057044 | ||
Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. | Q37250634 | ||
Enhancing the apoptotic and therapeutic effects of HDAC inhibitors | Q37440094 | ||
Histone deacetylase inhibitors and aspirin interact synergistically to induce cell death in ovarian cancer cells. | Q39968749 | ||
Tumor necrosis factor-alpha related gene response to Epothilone B in ovarian cancer | Q40572985 | ||
Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer | Q44342271 | ||
Dietary aspirin decreases the stage of ovarian cancer in the hen. | Q46262682 | ||
Cyclooxygenase-1 is overexpressed in multiple genetically engineered mouse models of epithelial ovarian cancer. | Q46970864 | ||
Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: implications for therapy. | Q53563335 | ||
Ovarian cancer | Q80994319 | ||
P433 | issue | 11 | |
P921 | main subject | ovarian cancer | Q172341 |
aspirin | Q18216 | ||
P304 | page(s) | 928-935 | |
P577 | publication date | 2010-06-25 | |
P1433 | published in | Cancer Biology and Therapy | Q2544651 |
P1476 | title | The effects of the histone deacetylase inhibitor romidepsin (FK228) are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer cells through augmentation of p21 | |
P478 | volume | 9 |